Clinical value of non-invasive prenatal testing for screening of fetal chromosome copy number variation

doi:10.3877/cma.j.issn.1673-5250.2022.03.008

Objective

To explore clinical value of non-invasive prenatal testing (NIPT) for screening of fetal chromosome copy number variation (CNV), mainly microdeletion/microduplication.

Methods

From January 2019 to October 2021, a total of 67 pregnant women whose results of NIPT showed fetal chromosomes deletions or repetitive abnormal in First Hospital of Shanxi Medical University, and then received interventional prenatal diagnosis, were selected as research subjects. Their clinical data were retrospectively analyzed. Fetal chromosome karyotype analysis and chromosome microarray analysis (CMA) were performed on amniotic fluid cells of pregnant women to analyze the consistency of fetal chromosome CNV between NIPT and interventional prenatal diagnosis. The procedure of this study was consistent with the Helsinki Declaration of World Medical Association revised in 2013. All pregnant women gave their informed consent to the above mentioned tests and sign the informed consent forms.

Results

① During above time period, there were 29 479 pregnant women who received NIPT and 87 cases showed abnormal of deletion or duplication of fetal chromosomes, and rate of fetal chromosome CNV was 0.30%(87/29 479). ② There were 35 cases diagnosed as fetal chromosomal CNV among 67 pregnant women who received interventional prenatal diagnosis, and the positive predictive value of NIPT screening for fetal chromosomal CNV was 52.2%(35/67). Among 67 pregnant women, 29 cases of CMA results of fetal chromosomal CNV were coincident with NIPT, and coincident rate of fetal chromosomal CNV detected by NIPT and CMA was 43.2%(29/67).

Conclusions

It is feasible of NIPT screening for fetal chromosome CNV. For those who have fetal chromosome CNV results of NIPT, prenatal diagnosis should be further taken to confirm the diagnosis.

Key words: Chromosomes, Noninvasive prenatal testing, DNA copy number variations, Prenatal diagnosis, Microdeletion, Microduplication, Microarray analysis, Pregnant women

表1 35例确诊为染色体CNV胎儿的NIPT及产前诊断结果比较

病例(No.)	NIPT结果	染色体核型分析结果	CMA结果	CNV分类
1	del(1q)，4.8 Mb	46，XN	del(1)(q43)，3.4 Mb	pCNV
2	del(1p)，3.08 Mb	46，XN	del(1)(p36.33 p36.32)，1.9 Mb	pCNV
3	20号染色体偏多	46，XN	del(1)(q21.3)，117.4 kb	良性CNV
4	dup(2q), 12.3 Mb	46，XN，add(2)(q34)	dup(2)(q34 q37.3)，33.4 Mb	均为pCNV
			dup(14)(q11.2q12)，5.4 Mb
5	del(2q12.12)，1.49 Mb	46，XN	del(2)(q21.1)，320.1 kb	临床意义不明确CNV
6	dup(4q)，5.5 Mb	46，XN	dup(3)(q21.2)，786.5 kb	均为pCNV
			dup(4)(q12)，3.9 Mb
7	3号染色体部分缺失	46，XN	del(3)(q25.32 q26.31)，14.8 Mb杂合性缺失	均为临床意义不明确CNV
8	del(4q), 9.96 Mb	46，XN，del(4)(q35)	del(4)(q34.3q35.2)，11.7 Mb	均为pCNV
			dup(3)(p26.3p26.)，3.8 Mb
9	dup(5q)，1.02 Mb	46，XN	dup(5)(q11.2)，809.0 kb	pCNV
10	dup(14q)，5.75 Mb	46，XN	dup(14)(q24.3q31.1)，1.3 Mb 2次重复	均为pCNV
11	22号染色体偏多	46，XN	dup(7)(p12.1p11.2)，4.3 Mb	pCNV
12	dup(7q)，4.91 Mb	46，XN	dup(7)(q36.3)，2.1 Mb	pCNV
			del(9)(p24.2)，115.7 kb	良性CNV
13	del(X)(q21.1-q28)，25.29Mb	46，XN	dup(8)(p21.2)，1.2 Mb	良性CNV
14	dup(8p)，5.38 Mb	46，XN	dup(8)(p23.2p23.1)，2.6 Mb	临床意义不明确CNV
15	del(9p)，15.05 Mb	46，XN，del(9)(p24)	del(9)(p24.3p23)，13.6 Mb	pCNV
16	10号染色体异常	46，XN，dup(10)(q26)	dup(10)(p15.3p12.1)，25.9 Mb	均为pCNV
			dup(10)(q26.13q26.2)，2.5 Mb
			del(10)(q26.2q26.3)，6.3 Mb
17	del(12p)，1.5 Mb	46，XN	del(12)(p11.23)510.1 kb	pCNV
18	del(12q)，6.8 Mb	46，XN	del(12)(q24.32q24.33)，4.2 Mb	pCNV
19	del(1p)，32.99 Mb	46，XN	dup(12)(q24.21)，250.1 kb	临床意义不明确CNV
20	del(13q)，18.51 Mb	46，XN，del(13)(q14)	del(2)(q21.1)，320.1 kb	均为pCNV
			del(13)(q21.2q21.33)，11.6 Mb
			del(13)(q21.33q31.1)，8.9 Mb
			del(20)(p12.3p12.2)，1.3 Mb
21	del(14q)，8.76 Mb	46，XN	del(14)(q13.3q21.2)，7.7 Mb	pCNV
22	del(14q) ，21.5 Mb	46，XN，del(14)(q32)	del(14)(q32.11q32.33)，17.2 Mb杂合性缺失	均为pCNV
23	性染色体偏多	45，X(12)/46，XN(88)	疑似有低比例45，X/46，XX，或XXX/X/XX，或XXX/X等性染色体嵌合del(15)(q15.2)，329.0 kb	均为pCNV
24	del(15)(q11.2-q13.1)，5.43 Mb	46，XN	del(15)(q11.2q13.1)，6.2 Mb	pCNV
25	11号染色体偏多	46，XN	dup(16)(p13.11)，1.6 Mb	pCNV
26	22号染色体偏多	46，XN	del(16)(p11.2)，946.9 kb	临床意义不明确CNV
27	15号染色体偏多	47，XN，+15(8)/ 46，XN(62)	胎儿疑似为低比例15号染色体三体嵌合体	临床意义不明确CNV
28	dup(17q)，3.5 Mb	46，XN	dup(17)(q12)，1.8 Mb	pCNV
29	dup(18p)，25.8 Mb	46，XY，der(18)t(18；21)？	dup(18)(p11.32q12.1)，31.2 Mb	pCNV
30	18-三体高风险	46，XN，+add(18)？	dup(18)(q11.1q12.1)，9.5 Mb	临床意义不明确CNV
31	del(18q22.2-q23)，10.33 Mb	46，XN，18？	dup(18)(p11.32p11.22)，9.6 Mb	均为pCNV
			del(18)(q22.2q23)，11.1 Mb
32	del(15q)，5.14 Mb	46，XN	del(15)(q21.3q22.2)，4.8 Mb	pCNV
33	del(21q)，9.05 Mb	46，XN	del(21)(q22.12q22.3)，11.3 Mb杂合性缺失	均为pCNV
34	20号染色体偏多	47，XN，+20(58)/ 46，XN(12)	2条20号染色体分别来自父母一方的单亲二体性	pCNV
35	dup(22q)，5.61 Mb	46，XN	dup(22)(q11.21q11.23)，3.5 Mb	pCNV

表1 35例确诊为染色体CNV胎儿的NIPT及产前诊断结果比较

病例(No.)	NIPT结果	染色体核型分析结果	CMA结果	CNV分类
1	del(1q)，4.8 Mb	46，XN	del(1)(q43)，3.4 Mb	pCNV
2	del(1p)，3.08 Mb	46，XN	del(1)(p36.33 p36.32)，1.9 Mb	pCNV
3	20号染色体偏多	46，XN	del(1)(q21.3)，117.4 kb	良性CNV
4	dup(2q), 12.3 Mb	46，XN，add(2)(q34)	dup(2)(q34 q37.3)，33.4 Mb	均为pCNV
			dup(14)(q11.2q12)，5.4 Mb
5	del(2q12.12)，1.49 Mb	46，XN	del(2)(q21.1)，320.1 kb	临床意义不明确CNV
6	dup(4q)，5.5 Mb	46，XN	dup(3)(q21.2)，786.5 kb	均为pCNV
			dup(4)(q12)，3.9 Mb
7	3号染色体部分缺失	46，XN	del(3)(q25.32 q26.31)，14.8 Mb杂合性缺失	均为临床意义不明确CNV
8	del(4q), 9.96 Mb	46，XN，del(4)(q35)	del(4)(q34.3q35.2)，11.7 Mb	均为pCNV
			dup(3)(p26.3p26.)，3.8 Mb
9	dup(5q)，1.02 Mb	46，XN	dup(5)(q11.2)，809.0 kb	pCNV
10	dup(14q)，5.75 Mb	46，XN	dup(14)(q24.3q31.1)，1.3 Mb 2次重复	均为pCNV
11	22号染色体偏多	46，XN	dup(7)(p12.1p11.2)，4.3 Mb	pCNV
12	dup(7q)，4.91 Mb	46，XN	dup(7)(q36.3)，2.1 Mb	pCNV
			del(9)(p24.2)，115.7 kb	良性CNV
13	del(X)(q21.1-q28)，25.29Mb	46，XN	dup(8)(p21.2)，1.2 Mb	良性CNV
14	dup(8p)，5.38 Mb	46，XN	dup(8)(p23.2p23.1)，2.6 Mb	临床意义不明确CNV
15	del(9p)，15.05 Mb	46，XN，del(9)(p24)	del(9)(p24.3p23)，13.6 Mb	pCNV
16	10号染色体异常	46，XN，dup(10)(q26)	dup(10)(p15.3p12.1)，25.9 Mb	均为pCNV
			dup(10)(q26.13q26.2)，2.5 Mb
			del(10)(q26.2q26.3)，6.3 Mb
17	del(12p)，1.5 Mb	46，XN	del(12)(p11.23)510.1 kb	pCNV
18	del(12q)，6.8 Mb	46，XN	del(12)(q24.32q24.33)，4.2 Mb	pCNV
19	del(1p)，32.99 Mb	46，XN	dup(12)(q24.21)，250.1 kb	临床意义不明确CNV
20	del(13q)，18.51 Mb	46，XN，del(13)(q14)	del(2)(q21.1)，320.1 kb	均为pCNV
			del(13)(q21.2q21.33)，11.6 Mb
			del(13)(q21.33q31.1)，8.9 Mb
			del(20)(p12.3p12.2)，1.3 Mb
21	del(14q)，8.76 Mb	46，XN	del(14)(q13.3q21.2)，7.7 Mb	pCNV
22	del(14q) ，21.5 Mb	46，XN，del(14)(q32)	del(14)(q32.11q32.33)，17.2 Mb杂合性缺失	均为pCNV
23	性染色体偏多	45，X(12)/46，XN(88)	疑似有低比例45，X/46，XX，或XXX/X/XX，或XXX/X等性染色体嵌合del(15)(q15.2)，329.0 kb	均为pCNV
24	del(15)(q11.2-q13.1)，5.43 Mb	46，XN	del(15)(q11.2q13.1)，6.2 Mb	pCNV
25	11号染色体偏多	46，XN	dup(16)(p13.11)，1.6 Mb	pCNV
26	22号染色体偏多	46，XN	del(16)(p11.2)，946.9 kb	临床意义不明确CNV
27	15号染色体偏多	47，XN，+15(8)/ 46，XN(62)	胎儿疑似为低比例15号染色体三体嵌合体	临床意义不明确CNV
28	dup(17q)，3.5 Mb	46，XN	dup(17)(q12)，1.8 Mb	pCNV
29	dup(18p)，25.8 Mb	46，XY，der(18)t(18；21)？	dup(18)(p11.32q12.1)，31.2 Mb	pCNV
30	18-三体高风险	46，XN，+add(18)？	dup(18)(q11.1q12.1)，9.5 Mb	临床意义不明确CNV
31	del(18q22.2-q23)，10.33 Mb	46，XN，18？	dup(18)(p11.32p11.22)，9.6 Mb	均为pCNV
			del(18)(q22.2q23)，11.1 Mb
32	del(15q)，5.14 Mb	46，XN	del(15)(q21.3q22.2)，4.8 Mb	pCNV
33	del(21q)，9.05 Mb	46，XN	del(21)(q22.12q22.3)，11.3 Mb杂合性缺失	均为pCNV
34	20号染色体偏多	47，XN，+20(58)/ 46，XN(12)	2条20号染色体分别来自父母一方的单亲二体性	pCNV
35	dup(22q)，5.61 Mb	46，XN	dup(22)(q11.21q11.23)，3.5 Mb	pCNV

[1]	Evans MI, Wapner RJ, Berkowitz RL. Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor[J]. Am J Obstet Gynecol, 2016, 215(3): 298-305. DOI: 10.1016/j.ajog.2016.04.029.
[2]	Pös O, Budis J, Kubiritova Z, et al. Identification of structural variation from NGS-based non-invasive prenatal testing[J]. Int J Mol Sci, 2019, 20(18): 4403. DOI: 10.3390/ijms20184403.
[3]	Li R, Wan J, Zhang Y, et al. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies[J]. Ultrasound Obstet Gynecol, 2016, 47(1): 53-57. DOI: 10.1002/uog.14911.
[4]	Simpson JL. Invasive procedures for prenatal diagnosis: any future left？[J]. Best Pract Res Clin Obstet Gynaecol, 2012, 26(5): 625-638. DOI: 10.1016/j.bpobgyn.2012.05.007.
[5]	蔡艾杞，章锦曼，唐新华，等. 胎儿拷贝数变异的产前诊断与遗传咨询[J/OL]. 中华妇幼临床医学杂志(电子版), 2021, 17(3): 262-267. DOI: 10.3877/cma.j.issn.1673-5250.2021.03.004.
[6]	靳倩，令狐克燕，卓召振，等. 1 674例孕妇羊水细胞G显带核型与染色体微阵列结果对比分析[J]. 中国计划生育学杂志，2021, 29(5): 1046-1049. DOI: 10.3969/j.issn.1004-8189.2021.05.047.
[7]	郑静，卓越，刘艳妮. 羊水细胞原位培养及核型制备方法的改进[J]. 医学研究生学报，2019, 32(3): 282-285. DOI: 10.16571/j.cnki.1008-8199.2019.03.012.
[8]	McGowan-Jordan J, Simons A, Schmid M. ISCN 2016: an international system for human cytogenetic nomenclature (2016)[M]. Basel: S. Karger AG, 2016.
[9]	张文玲，刘晓婷，张立文，等. 染色体微阵列分析技术在产前诊断中的应用综述[J]. 解放军医学院学报，2018, 39(12): 1110-1113. DOI: 10.3969/j.issn.2095-5227.2018.12.020.
[10]	王秋菊，沈亦平，陈少科，等. 遗传变异分类标准与指南[J]. 中国科学(生命科学), 2017, 47(6): 668-688. DOI: 10.1360/N052017-00099.
[11]	戚庆炜. 无创产前检测临床应用相关指南解读[J]. 发育医学电子杂志，2019, 7(3): 161-167. DOI: 10.3969/j.issn.2095-5340.2019.03.001.
[12]	刘俊涛. 无创产前检测国际指南与中国规范[J]. 中国实用妇科与产科杂志，2017, 33(6): 564-567. DOI: 10.19538/j.fk2017060104.
[13]	Kearney HM, South ST, Wolff DJ, et al. American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities[J]. Genet Med, 2011, 13(7): 676-679. DOI: 0.1097/GIM.0b013e31822272ac.
[14]	卢建，侯亚萍，黄伟伟，等. 471例NIPT阳性孕妇产前诊断结果分析[J/OL]. 中国产前诊断杂志(电子版), 2017, 9(4): 14-17. DOI: 10.13470/j.cnki.cjpd.2017.04.003.
[15]	刘学军，刘慈，马良，等. 无创产前筛查检测胎儿染色体缺失或重复的应用价值分析[J]. 中国优生与遗传杂志，2019, 27(7): 811-813, 860.
[16]	谢润桂，魏顺娣，何晓旋，等. 无创产前检测筛查拷贝数变异的临床应用价值探讨[J]. 右江医学，2020, 48(4): 266-271. DOI: 10.3969/j.issn.1003-1383.2020.04.006.

[1]	Zhong Yang, Jingye Shi, Xuedong Deng, Wei Jiang, Linliang Yin, Qi Pan, Hong Liang, Jianfang Ma, Zhenqi Wang, Jun Zhang, Shanshan Dong. Diagnostic value of prenatal ultrasound in fetal 22q11.2 microdeletion syndrome[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(09): 852-858.
[2]	Lili Gu, Fan Jiang. Survey and analysis of quality of screening prenatal ultrasound images in Anhui Province[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 671-674.
[3]	Yan Xu, Tong Ru, Mingming Zheng, Yan Gu, Xiangyu Zhu, Chenchen Yan, Ling Chen, Chenyan Dai. Prenatal ultrasound and MRI characteristics and genetic analysis of Miller-Dieker syndrome[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(03): 281-287.
[4]	Jingyu Qian, Mingming Zheng. Interpretation of the Italian guidelines on non-invasive and invasive prenatal diagnosis：executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology（SIGO）[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 486-492.
[5]	Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[6]	Ziyang Liu, Jianjian Cui, Yin Zhao. Current research status on obstetric disseminated intravascular coagulation and its scoring system[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 511-518.
[7]	Fanying Zeng, Jie Ruan, Xinghui Liu, Guolin He. Current status of perinatal medicine advances under the new reproductive situation and coping strategies in prenatal care[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 519-524.
[8]	Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[9]	Rong Huang, Ziyu Liang, Wenjin Qi. Expression and significance of NLRP3 inflammasome in serum of pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 540-548.
[10]	Xia He, Rong Huang, Wenjin Qi. High-throughput sequencing study on the abundance of placenta and fetal membrane flora in pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 549-555.
[11]	Jiangyan Xie, Yafei Wang, Fang He. Pregnancy complicated with thrombotic thrombocytopenic purpura：two cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 556-563.
[12]	Tingting Xu, Yongchi Zhan, Xiaodong Wang, Xiaodong Wang. Perinatal outcomes of fetomaternal hemorrhage syndrome pregnant women with sinusoidal fetal heart tracing[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 382-389.
[13]	Xiaoyan Han, Hua Yang. Relationship between low level of serum placental growth factor in the second trimester pregnancy women and adverse fetal prognosis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 398-402.
[14]	Jiali Du, Rui Bao, Chunhong Qiao, Wei Han. Construction of a prediction model for adverse pregnancy outcomes after emergency cervical cerclage in pregnant women with cervical incompetence during the second trimester[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 403-409.
[15]	Xiaorong Peng, Wei Mo, Qin Li, Yaqin Wu, Lan Li. Knowledge, attitude and practice of venous thromboembolism prevention and influencing factors among pregnant women[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2024, 12(03): 274-280.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export